| Literature DB >> 30374125 |
Muhammad A B Siddik1, Janet Howieson2, Gavin J Partridge3,4, Ravi Fotedar2, Hosna Gholipourkanani5.
Abstract
This study investigated the effects of tuna hydrolysate (TH) inclusion in fishmeal (FM) based diets on the growth performance, innate immune response, intestinal health and resistance to Streptococcus iniae infection in juvenile barramundi, Lates calcarifer. Five isonitrogenous and isoenergetic experimental diets were prepared with TH, replacing FM at levels of 0% (control) 5%, 10%, 15% and 20%, and fed fish to apparent satiation three times daily for 8 weeks. The results showed that fish fed diets containing 5% and 10% TH had significantly higher final body weight and specific growth rate than the control. A significant reduction in blood glucose was found in fish fed 10%, 15% and 20% TH compared to those in the control whereas none of the other measured blood and serum indices were influenced by TH inclusion. Histological observation revealed a significant enhancement in goblet cell numbers in distal intestine of fish fed 5 to 10% TH in the diet. Moreover, fish fed 10% TH exhibited the highest resistance against Streptococcus iniae infection during a bacterial challenge trial. These findings therefore demonstrate that the replacement of 5 to 10% FM with TH improves growth, immune response, intestinal health and disease resistance in juvenile barramundi.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30374125 PMCID: PMC6206086 DOI: 10.1038/s41598-018-34182-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Growth performance and feed utilization of juvenile barramundi (initial body weight, 12.23 ± 0.41 g) fed tuna hydrolysate (TH) included diets at various levels for 8 weeks.
| Parameters | Experimental diets | ANOVA P | ||||
|---|---|---|---|---|---|---|
| Control | TH05 | TH10 | TH15 | TH20 | ||
| FBW (g) | 78.17b ± 1.17 | 85.37a ± 1.79 | 85.05a ± 1.08 | 81.72ab ± 1.21 | 80.67ab ± 1.60 | 0.021 |
| SGR (%/d) | 3.31b ± 0.03 | 3.47a ± 0.04 | 3.46a ± 0.02 | 3.39ab ± 0.03 | 3.37ab ± 0.04 | 0.020 |
| FI (g/fish/day) | 1.46 ± 0.01 | 1.47 ± 0.02 | 1.49 ± 0.01 | 1.47 ± 0.01 | 1.46 ± 0.01 | 0.831 |
| FCR | 1.24 ± 0.03 | 1.13 ± 0.03 | 1.13 ± 0.03 | 1.19 ± 0.02 | 1.20 ± 0.03 | 0.056 |
| Survival (%) | 100.00 ± 0.00 | 100.00 ± 0.00 | 98.33 ± 1.67 | 98.33 ± 1.67 | 96.67 ± 1.67 | 0.512 |
Different superscript letters (a,b,c) in the same row denote significant differences (p < 0.05). Data were represented as mean ± SE.
FBW: mean final body weight (g).
SGR: specific growth rate = [(ln final body weight − ln (pooled initial body weight))/days] × 100
FI: feed intake = dry feed consumed/fish number.
FCR: feed conversion ratio = dry feed fed/wet weight gain.
Survival (%) = (number of final fish − number of initial fish)/number of initial fish × 100.
Figure 1Quadratic regression analysis of final body weight (FBW) for juvenile barramundi fed diets at varying levels of tuna hydrolysate (TH) for 8 weeks. X-axis represents the TH inclusion levels of 0 (control), 5, 10, 15 and 20 are considered as experimental treatments. The multiplication sign ‘X’ represents the TH level for the highest FBW for juvenile barramundi. Each point in the graph represents one treatment with the mean of three replicate groups of fish. The optimal TH level obtained with the quadratic regression analysis for FBW was 10.5% in the diet, respectively.
Figure 2Blood and serum biochemical parameters of juvenile barramundi fed tuna hydrolysate (TH) included diets at various levels for 8 weeks. X-axis represents the TH inclusion levels of 0 (control), 5, 10, 15 and 20 are considered as experimental treatments. (A) AST, aspartate transaminase (B) GLDH, glutamate dehydrogenase (C) total protein (D) glucose (E) globulin (F) albumin (G) A/G ratio (albumin/globulin ratio) and (H) hematocrit. Data were represented as mean ± S.E., n = 3. Post ANOVA Turkey multiple comparison test was applied to compare the mean value of each treatment with the mean value of the control. Mean values significantly different from the control are noted with P < 0.05.
Figure 3Representative micrographs of liver, spleen, muscle and intestine of juvenile barramundi after 8 weeks of being fed with control, TH10 and TH20. (A–C) Liver histology from control (A) and TH20 (C) contain increased lipid deposition in hepatocytes while normal cells were observed in TH10 (B) fed fish. (D–F) Light micrographs of spleen showing marked melanomacrophage aggregates in TH20 (F) whereas such cases were not observed in control (D) and TH10 (E) diets. (G–I) Muscle tissues containing different diets showed healthy myotomes characterised by rounded, packed and uniformly identical muscle fibres. (J–L) The distal intestine of fish fed TH20 (L) showing reduced mucosal fold lengths and loss of epidermal integrity whereas control (J) and TH10 (K) fed fish intestinal fold were appear to be healthy with no obvious signs of intestinal inflammation. (LD = lipid droplet; MC = melanomacrophages complex; WP = white pulps; HM = healthy myotome; SF = short fold. All sections are stained with H&E. Scale bar, 50 μm.
Figure 4Transverse sections of distal intestine photomicrograph of the juvenile barramundi (Panel A–D). All sections are stained with H&E. Scale bar, 50 μm, inset 20 µm. X-axis represents the TH inclusion levels of 0 (control), 5, 10, 15 and 20 are considered as experimental treatments (E–H). The distal intestine of juvenile barramundi is influenced by the inclusion of tuna hydrolysate (TH) in diets at varying levels for 8 weeks. The different measurements include GC = Goblet cells (Panel E), hF = fold height (Panel F), hMV = microvillous height (Panel G), ECS = external circumference of serosa (Panel H). Arrow point and cartoon with bracket both indicate hMV (Panel C). Data were represented as mean ± S.E., n = 5. Post ANOVA Tukey multiple comparison test was applied to compare the mean value of each treatment with the mean value of the control. Mean values significantly different from the control are noted with P < 0.05, P < 0.01 and P < 0.001.
Figure 5Serum lysozyme (A) and complement (B) activities of juvenile barramundi fed TH diets at different inclusion levels for 8 weeks. Data were expressed as mean ± SE. X-axis represents the TH inclusion levels of 0 (control), 5, 10, 15 and 20 are considered as experimental treatments. Different lowercase letters (a,b,c) denote statistically significant differences among pre-challenge, post-challenge-24 h and post- challenge- 7 d in the same treatment. Bars holding same uppercase letter (A) among the different experimental treatments are not statistically significant. (Multifactorial ANOVA; Tukey post-hoc test; not significant P > 0.05; significant P < 0.05; P < 0.001).
Two-way ANOVA analysis on the effect of experimental diets and their challenge period (pre, post-24 and 7 d) and their respective interactions on lysozyme and complement activity.
| Parameter | Factors | Interaction | |
|---|---|---|---|
| Challenge period | Diets | Challenge period × Diets | |
| Lysozyme activity | 0.000 | 0.063 | 0.068 |
| Complement (ACTH) activity | 0.000 | 0.308 | 0.268 |
Multifactorial ANOVA; Tukey post-hoc test; not significant P > 0.05; significant P < 0.05; P < 0.001.
Figure 6The Kaplan Meyer’s survival analysis of juvenile barramundi after immersion challenge with Streptococcus iniae. Survival curves displaying the outcome of bacterial challenge where n = 30 for each treatment. Infection in control started at 3 days post challenge (dpc), 4 dpc in the TH15 and TH20, while infection started in TH05 and TH10 at 5 and 6 dpc, respectively. Significantly higher post challenge survival was found in TH05 and TH10 fish (p = 0.030 and 0.004, respectively) when compared with control. Asterisks * and ** indicate statistically significant difference between treated group and infected control at p < 0.05 and p < 0.01, respectively.
Formulation and proximate composition of the experimental diets for juvenile barramundi.
| Ingredients (g kg−1)a | Experimental diets | ||||
|---|---|---|---|---|---|
| Control | TH05 | TH10 | TH15 | TH20 | |
| Fish meal | 610.0 | 579.5 | 549.0 | 518.5 | 488.0 |
| Tuna hydrolysate | — | 30.5 | 61.0 | 91.5 | 122.0 |
| Wheat | 266.0 | 260.0 | 254.0 | 248.0 | 240.0 |
| Wheat starch | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 |
| Fish Oil | 30.0 | 30.0 | 30.0 | 30.0 | 30.0 |
| Calcium carbonate | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 |
| Salt (NaCl) | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 |
| Vitamin premixb | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| Casein | 63.0 | 69.0 | 75.0 | 81.0 | 89.0 |
| Cellulose | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 |
|
| |||||
| Dry matter | 92.72 | 91.05 | 90.38 | 89.71 | 89.04 |
| Crude protein | 47.10 | 47.16 | 47.14 | 47.12 | 47.18 |
| Crude lipid | 9.99 | 9.88 | 9.96 | 9.94 | 9.92 |
| Ash | 13.04 | 12.56 | 12.09 | 11.61 | 11.14 |
| NFEc | 22.59 | 21.45 | 21.19 | 21.04 | 20.80 |
| Gross energy (MJkg−1) | 19.98 | 19.97 | 19.96 | 19.95 | 19.97 |
aSupplied by Specialty Feeds, Perth, Australia.
bVitamin premix (g/kg): iron, 10; copper, 1.5; iodine, 0.15;manganese, 9.5; zinc, 25; vitamin A retinol, 100 IU; vitamin D3, 100 IU; vitamin E, 6.25; vitamin K, 1.6; vitamin B1, 1; vitamin B2, 2.5; niacin, 20; vitamin B6, 1.5; calcium, 5.5; biotin, 0.1; folic acid, 0.4; inositol, 60; vitamin B12, 0.002; choline, 150; ethoxyquin, 0.125.
cNitrogen free extracts (NFE) = dry matter − (crude lipid + crude ash + crude protein).